Tissue Activity Biomarker Estimation from Noisy Diffusion MRI
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for estimating biomarkers from diffusion MRI data are hindered by high computation time, noise sensitivity, and low sampling, leading to unreliable and biased estimates of microscopic phenomena in tissues.
Innovation Solution
A method for quantifying a novel biomarker, the Tissue Activity Indicator (TAI), calculated as the integral of a bijective transformation of experimental data over a range of diffusion gradient values, providing a robust and rapid estimation of tissue activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional methods are used to estimate biomarkers from diffusion MRI data, then the estimation process can be performed, but the computation time is high and the estimates are noisy and biased
Solution Approach 1:
The invention extracts only the essential information needed for accurate biomarker estimation by formulating an optimization problem that selects optimal diffusion gradient values. This extraction approach avoids unnecessary computations while preserving the critical data needed for precise tissue activity quantification, thereby reducing computation time without sacrificing accuracy.
Solution Approach 2:
The invention changes the parameters by selecting optimal diffusion gradient values that maximize information content while minimizing computation. By transforming the estimation problem into an optimization framework with specific gradient value selection, the method achieves both speed and accuracy improvements over conventional approaches.
2Reliability
If conventional methods are used to estimate biomarkers from diffusion MRI data, then the estimation process can be performed, but the results are highly sensitive to noise
Solution Approach 1:
The invention converts the harmful effect of noise into a benefit by formulating an optimization problem that explicitly accounts for noise characteristics. The optimal diffusion gradient selection criteria are designed to maximize signal-to-noise ratio and minimize the impact of noise on estimation reliability, thereby transforming noise sensitivity into a robust estimation method.
Solution Approach 2:
The invention implements feedback by using an optimization framework that iteratively refines the selection of diffusion gradient values based on their expected contribution to estimation accuracy. This feedback mechanism ensures that only the most informative and noise-resistant gradient values are selected, improving overall reliability while reducing noise sensitivity.
3Productivity
If conventional methods are used to estimate biomarkers from diffusion MRI data, then the estimation can be performed with low sampling, but the estimates become unreliable and biased
Solution Approach 1:
The invention performs preliminary action by pre-selecting optimal diffusion gradient values before actual data acquisition. This pre-selection ensures that the limited sampling obtained during acquisition is maximally informative, allowing reliable biomarker estimation even with low sampling density. The optimization framework identifies the most valuable gradient values in advance, eliminating the need for extensive sampling.
Solution Approach 2:
The invention maintains continuity of useful action by ensuring that each acquired data point contributes maximally to the final estimation through optimal gradient selection. The optimization framework guarantees that the continuous acquisition process captures only the most informative signals, maintaining estimation precision throughout the entire acquisition sequence even with limited sampling.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The TAI biomarker is resistant to noise and computation-intensive processes, enabling accurate and efficient quantification of tissue activity, enhancing diagnostic precision in applications like cancer analysis and stroke evaluation.
Implementation Method 1
the device applies a combination of high-frequency electromagnetic waves to the body part in question and measures the signal re-emitted by certain atoms, such as, but not limited to, hydrogen for Nuclear Magnetic Resonance (NMR) imaging
Implementation Method 2
These techniques allow for the rapid acquisition of valuable information about the movement of water molecules within organs or tissues in humans or animals
Data Source
Figure 1~2
Figure 3~4
Figure 5~6A
AI summary
The invention relates to a system and method (100) for quantifying a novel biomarker (TAI) of the tissue activity of a human or animal organ. By way of preferred application, such a biomarker (TAI) describes the diffusivity of biological fluids in living tissues in the form of a novel indicator of the diffusion of water molecules in living tissues on the basis of diffusion data resulting from the acquisition of a sequence of images of one or more parts of the body of an animal or human patient. Particularly resistant and stable with respect to noise present in the medical imaging signals from which the experimental data stem, the novel biomarker (TAI) is relevant in a large number of applications including, inexhaustively, the analysis and/or monitoring of cancers, or the assessment of strokes.